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Abstract
Background: Sarcoidosis is rarely associated with a distinct disease. One disease infrequently
associated with sarcoidosis is psoriasis.
Case presentation: This case study describes a 38-year-old male, who presented with chest pain,
high-grade fever, arthralgias and a skin rash accompanied by bilateral hilar lymphadenopathy on his
chest radiograph. Extensive investigations including fiber-optic bronchoscopy with bronchoalveolar
lavage and labial and skin biopsies, demonstrated that two distinct clinical entities co-existed in the
same patient: pulmonary sarcoidosis and psoriasis vulgaris. Combination therapy for both diseases
was applied and the patient was greatly improved.
Conclusion: This is the first well-documented case of sarcoidosis and psoriasis in the same
patient, reported on the basis of safe and widely-used techniques that were not available until fairly
recently. These disorders might share common pathogenic mechanisms that could explain their co-
existence in the patient.
Background
About 25% of sarcoidosis patients may suffer from skin
lesions during the course of their disease [1]. Psoriasiform
lesions have been reported in sarcoidosis [2-6]. In this
paper we present a patient who showed clinical and histo-
logical features compatible with both pulmonary sar-
coidosis and psoriasis vulgaris.
Case presentation
A 38-year-old male, a heavy smoker, was admitted to our
department, because of fever (38.4°C), weakness, arthral-
gias, non-pitting edema of the lower extremities and chest
discomfort for the previous two weeks. The arthralgias
were partially responsive to nonsteroidal anti-inflamma-
tory drugs (NSAIDs). The patient also reported skin erup-
tions on his elbows and lower extremities that had
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was unremarkable.
On physical examination, sharply demarcated erythema-
tous plaques covered by silvery white scales were observed
on the right elbow and the lower extremities below the
knees (figure 1). The patient's ankles were painful and
edematous. On palpation, firm and painless subcutane-
ous nodules could be found on the occipital part of the
scalp. The rest of the physical examination was unremark-
able.
Basic laboratory tests were normal except for an increased
erythrocyte sedimentation rate (57 mm/h) and C-reactive
protein (45.2 mg/l). Further investigations, which
included serum complement analysis, rheumatoid factor,
antinuclear antibodies, antineutrophilic cytoplasmatic
antibodies, immunoglobulin levels, and serological tests
for hepatitis A, B and C and human immunodeficiency
virus, disclosed no apparent pathologies. PPD skin test
was negative. Neither arterial blood gases nor pulmonary
function tests showed significant abnormalities. Radio-
graphic examination, using x-ray and high resolution
computed tomography of the chest, revealed bilateral
hilar and right paratracheal lymphadenopathy with small
nodules along the bronchovascular bundles. Fiber-optic
bronchoscopy and bronchoalveolar lavage (BAL) were
performed. BAL fluid analysis revealed lymphocytosis
(35%) with an increased CD4+/CD8+ ratio (4.2). Micro-
biological and cytological examinations were negative.
Transbronchial lung biopsies were non-diagnostic.
A labial biopsy and biopsies from the cutaneous lesions
were also obtained. The labial biopsy demonstrated the
presence of small epithelioid (sarcoid form) granulomas
(figure 2), while the skin biopsies were typical of psoriasis
(figure 3). Immunohistochemical analysis of tissue sam-
ples with periodic acid-Schiff staining was negative. We
concluded that the patient suffered from two separate
clinical entities: pulmonary sarcoidosis and psoriasis vul-
garis.
The articular manifestations responded partially to
NSAIDs. Consequently, a short course of 30 mg pred-
nisone daily and topical therapy to manage the psoriatic
lesions were applied. This resulted in a significant clinical
improvement. Three months after his discharge the
patient remains asymptomatic.
Discussion
Sarcoidosis is predominantly seen in young and middle-
aged patients and may involve multiple organs [7].
Although the cause of sarcoidosis remains uncertain,
much is known about the immunology of this disease.
The immunological hallmark is an accumulation of acti-
vated CD4+ T lymphocytes at the sites of inflammation.
Interaction between the CD4+ cells and alveolar macro-
phages leads to a Th1-skewed cytokine profile that orches-
trates the ensuing granulomatous inflammatory process
[8].
The diagnosis of sarcoidosis is commonly established on
the basis of compatible clinical and/or radiological fea-
tures, supported by the histological findings of noncaseat-
ing granulomas and the exclusion of other diseases with a
similar clinical or histological picture [7]. The recom-
A labial biopsy reveals lobules of small salivary glands and a sm ll, non-necrotic, sarcoid type epithelioid granulom  (arrow)Figure 2
A labial biopsy reveals lobules of small salivary glands and a 
small, non-necrotic, sarcoid type epithelioid granuloma 
(arrow). (Haematoxylin & Eosin, original magnification ×100).
Scaly erythematous plaques of the lower extremity (psoriasis vulgaris)Figu e 1
Scaly erythematous plaques of the lower extremity (psoriasis 
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combined with various biopsy techniques (endobron-
chial biopsy, transbronchial lung biopsy, transbronchial
needle aspiration and biopsy) as well as BAL. Studies of
the lymphocyte subpopulations in the BAL fluid may be
diagnostically important. A CD4+/CD8+ ratio of >3.5 in a
patient with a typical clinical and radiological picture is
very specific for sarcoidosis and may obviate the need for
further invasive diagnostic procedures [8]. If bronchos-
copy fails to confirm the diagnosis, labial biopsy is a fairly
useful method for providing histological confirmation of
the disease [9]. In the case presented here, the compatible
radiographic findings, the results of BAL fluid analysis and
the characteristic histological findings from the lip biopsy
were considered sufficient to support the diagnosis of sar-
coidosis.
Psoriasis is a common inflammatory skin disorder charac-
terized by erythematous, sharply demarcated papules and
rounded plaques, covered by silvery micaceous scales
which most commonly appear on the elbows, knees,
scalp, umbilicus and lumbar area [10]. Skin biopsy may
show a variable histological picture but is usually diagnos-
tic in early lesions or at the advancing edge of a well-estab-
lished plaque. The characteristic histological features in
psoriasis include proliferation of epidermal keratinocytes
and hyperkeratosis as well as infiltration of immunocytes
along with angiogenesis, and subsequent typical thicken-
ing and scaling of the erythematous skin. More specifi-
cally, the epidermis in psoriatic skin is characterized by
dramatic pathological alterations, such as profound acan-
thosis with elongation of epidermal rete ridges. Likewise,
neutrophils migrate through the epidermis and form
Munro microabscesses beneath the stratum corneum; this
is one of the most salient features of the disease [10]. The
findings from skin lesions in our patient were identical to
those mentioned above.
Compelling circumstantial and experimental evidence
suggests that the primary immunopathogenesis of psoria-
sis is T-lymphocyte based, so least in part it resembles sar-
coidosis. The immigrant immunocytes interact with
resident epithelial and mesenchymal cells to generate the
psoriatic lesion. Once activated, the T-lymphocytes
excrete a panel of Th1-type proinflammatory cytokines,
which are thought to explain many of the histopathologi-
cal changes seen in psoriatic skin. It is likely that the
inflammation of psoriasis is a balance between the adap-
tive (T-cell mediated) immune response and innate
immune responses [11].
Sarcoidosis is rarely associated with other diseases, and
most of these are characterized by a Th1/Th2 imbalance
(common variable immunodeficiency, autoimmune dis-
eases etc.) [12]. Moreover, the skin manifestations in sar-
coidosis are not always granulomatous (e.g. erythema
nodosum) and may result from a systemic immunological
reaction. Such a reaction might explain the presence of
psoriatic lesions in a patient with sarcoidosis. Thus the
coexistence of sarcoidosis and psoriasis might not be coin-
cidental. Both diseases share common pathogenic path-
ways and the occurrence of psoriasis in a sarcoidosis
patient might result from a variable response to a com-
mon antigenic stimulus. Enhancement of the Th1
immune response is well recognized in both diseases.
Moreover, the promising results obtained in both sar-
coidosis and psoriasis patients after application of anti-
TNF alpha agents (e.g. infliximab, adalimumab, etaner-
cept) further support this hypothesis, since these thera-
peutic agents may alter pathogenic mechanisms common
to both disorders [11,13-15]. It has also been reported
that the expression of pso p27, a psoriatic scale antigen
linked to the pathogenesis of psoriasis, is markedly
increased in the lungs of patients with pulmonary sar-
coidosis [16].
Conclusion
The number of patients reported with this combination of
diseases (sarcoidosis and psoriasis) is small and more
data are necessary to clarify the relationship. This is the
first reported case of pulmonary sarcoidosis and psoriasis
diagnosed by simple, safe and novel routine procedures.
The coexistence of these disorders supports the hypothesis
that they share common pathogenic mechanisms.
A skin biopsy reveals acanthosis of epidermis, with elongated rete ridges, thin suprap pillary epid rmal plates, absent gran-ular layer and hyperker tosisFigu e 3
A skin biopsy reveals acanthosis of epidermis, with elongated 
rete ridges, thin suprapapillary epidermal plates, absent gran-
ular layer and hyperkeratosis. A Munro microabscess 
(arrow) is also noticed within the parakeratotic cornified 
layer. (Haematoxylin & Eosin, original magnification ×100).Page 3 of 4
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NSAIDs: non-steroidal anti-inflammatory drugs, PPD:
purified protein derivative, BAL: bronchoalveolar lavage.
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